PDS Biotechnology's total assets for Q2 2025 were $40.48M, a decrease of -13.93% from the previous quarter. PDSB total liabilities were $24.52M for the fiscal quarter, a -0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.